Fluconazole — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

5 Recruiting

3 Completed trials

10 Sponsors

12 Countries

Phase III

Phase IV

Phase III: 4 Phase II: 1 Phase IV: 6

Oversight events:

7 temporary halts 1 corrective measure across 2 trials

View oversight register →

Indications tested

Fungal infection 1 Vulvovaginal candidiasis 1

Sponsors using this IMP

Rigshospitalet 2 Amsterdam UMC 1 Assistance Publique Hopitaux De Paris 1 Basilea Pharmaceutica International AG Allschwil 1 Centre Hospitalier Universitaire Vaudois 1 HUS-Yhtymae 1 Mundipharma Research Limited 1 Palau Pharma S.L. 1 Radboud universitair medisch centrum Stichting 1 Scynexis Inc. 1

All trials

11 total

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Phase III 1 country Assistance Publique Hopitaux De Paris
PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acu… Pending

2024-517211-79-00 Phase IV 2 countries Centre Hospitalier Universitaire Vaudois
Antimicrobial treatment of laryngeal leukoplakia Pending

2024-518793-14-00 Phase IV 1 country HUS-Yhtymae
Effect of antifungals on the intestinal microbiome – a randomized, controlled, proof-of-concept trial Recruiting

2023-503710-69-00 Phase IV 1 country Amsterdam UMC
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Phase IV 1 country Rigshospitalet
A Phase 3 efficacy and safety study of fosmanogepix for the treatment of adult participants with candidemia and/or invasive candidiasis. Recruiting

2022-500455-23-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal inf… Recruiting

2024-518305-17-01 Phase IV 1 country Radboud universitair medisch centrum Stichting
IMPACT – the introduction of mycotic prophylaxis at cystectomy trial. Recruiting

2023-506226-36-00 Phase IV 1 country Rigshospitalet
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Phase II 2 countries Palau Pharma S.L.
Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended

2024-511755-18-00 Phase III 7 countries Scynexis Inc.
A Phase 3 Study of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in AdultsUndergoin… Ended

2024-514471-18-00 Phase III 5 countries Mundipharma Research Limited

Showing 1–11 of 11 trials

← All drugs A–Z